[Effect of Craviten on blood dopamine beta-hydroxylase activity].
D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D004299:Dopamine beta-Hydroxylase / Q000097:blood*; D005029:Ethylenediamines / Q000378:metabolism / Q000494:pharmacology*; D006801:Humans
D000889:Anti-Arrhythmia Agents; D005029:Ethylenediamines; C030706:butobendin; D004299:Dopamine beta-Hydroxylase
Wpływ Cravitenu na aktywność beta-hydroksylazy dopaminy w surowicy krwi.